Biostat STR® and RM — an Unrivaled Modular Seed Train for Process Intensification
Many biopharmaceutical manufacturers won’t achieve the full impact of perfusion-based process intensification because they lack the technology to develop processes that transfer to manufacturing scale.
In this webinar, Sartorius experts present a modular, perfusion-enabled seed train featuring the Biostat® RM followed by a seamless seed transfer to the Biostat STR® which, combined with ATF filtration and PAT, enables implementation at large scale
Key Learning Objectives
Explore a modular, perfusion-enabled intensified seed train concept
Determine the appropriate seed train concept to meet specific needs
Assess the time/cost benefits based on pre-determined process type (e.g., fed-batch, n-1 perfusion, etc.) and scalable process development
Meet Our Expert
Dr. Yuliya Mikhed
Product Manager Biostat RM Bioreactors
Dr. Yuliya Mikhed, product manager at Sartorius, holds global responsibility for the Biostat® RM portfolio, including hardware and corresponding single-use consumables.
Yuliya studied medicinal chemistry at the University of Illinois at Chicago and earned a Doctor of Philosophy degree in molecular biology from Johannes Gutenberg University in Mainz, Germany. She published multiple peer-reviewed articles in the field of free radical biology and DNA mutagenesis.